T

Trefoil Therapeutics

17 employees

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics
Biotechnology and Ophthalmology

Date founded

2013

Funding rounds raised

Total raised

$28M

from 10 investors over 10 rounds

T

Trefoil Therapeutics raised undisclosed on January 1, 2020

Investors: Solasta Ventures

T

Trefoil Therapeutics raised $28M on July 16, 2019

Investors: Correlation Ventures, InFocus Capital Partners, Bios Partners, - and AJU IB INVESTMENT

T

Trefoil Therapeutics raised $5.2M on January 5, 2017

Investors: InFocus Capital Partners, AJU IB INVESTMENT and -

T

Trefoil Therapeutics raised undisclosed on October 20, 2015

Investors: National Institutes of Health

FAQ